Factors determining long-term function of renal allograft;Czynniki określajace długotrwała funkcje alloprzeszczepu nerki

Advances in Clinical and Experimental Medicine

Volumn 12, Issue 1, 2003, Pages 59-68

  Szepietowski, Tomasz ^a   Klinger, Marian ^a   Myszka Bijak, Krystyna ^a   Smolska, Danuta ^a   Boratyńska, Maria ^a   Falkiewicz, Krzysztof ^a   Kazimierczak, Krzysztof ^a   Szyber, Piotr ^b   Patrzalek, Dariusz ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Katedra i Klinika Chirurgii   (Poland)

Author keywords

Renal allograft; Renal graft function

Indexed keywords

AZATHIOPRINE; CHOLESTEROL; CLONIDINE; CREATININE; CYCLOSPORIN; CYCLOSPORIN A; HLA ANTIBODY; HLA ANTIGEN; IPOREL; METHYLPREDNISOLONE SODIUM SUCCINATE; METOCARD; METOPROLOL; OKT 3; PLASMA PROTEIN; PRAZOSIN; PREDNISONE; SERUM ALBUMIN; THYMOCYTE ANTIBODY; TRIACYLGLYCEROL; VERAPAMIL;

ACUTE GRAFT REJECTION; ADULT; ALBUMIN BLOOD LEVEL; ARTERIAL PRESSURE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEINURIA; RECIPIENT; RETROSPECTIVE STUDY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0037222319     PISSN: 1230025X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Burke B. A., Chavers B. M., Gillingham K. J., Kashtan C. S., Mnivel J. C., Mauer S. M., Nevins T. E., Matas A. J.: Chronic renal allograft rejection in the first 6 months posttransplant. Transplantation 1995,60,1413-141.
2. Lemstrom K., Koskinen P., Hayry P.: Molecular mechanisms of chronic renal allograft rejection. Kidney Int. 1995,48, S2-S5.
3. Ong A. C. M., Fine L. G.: Tubular derived growth factors and cytokines in the pathogenesis of tubulointerstitils fibrosis implications for human renal disease progression. Am. J. Kidney Dis. 1994,23, 205-209.
4. Tullius S. G., Tilney N. L.: Both alloantigen-dependent and independent factors influence chronic allograft rejection. Transplantation 1995, 59, 313-318.
5. Isoniemi H., Taskinen E., Hayry P.: Histological chronic allograft damege index accurately predicts chronic renal allograft rejection. Transplantation 1994, 58, 1195-1198.
6. Kumar M. S. A., Panigrahi D., Dezil C. M., Abouna G. M., Chvala R., Bresin J., Kumar A. M. S., Katz S. M., McSorely M., Laskow D. A.: Long-term function and survival of erderly donor kidneys transplanted into zoung adults. Transplantation 1998, 65, 282-285.
7. Terasaki P. I., Gjertson D. W., Cecka J. M. Cho Z., Takemoto S., Cohn M.: Significance of the donor age effect on kidney transplants. Clin. Transplant. 1997, 11, 365-372.
8. Teplan V., Poledne R., Schuck O., Ritz E., Vitko S.: Hyperlipidemia and obesity after renal transplantation. Ann. Transplant. 2001, 6, 21-23.
9. Njengaard J. R., Bendtsen T. F.: Glomerular number and size in relation to age, kidney weight and body surface in normal man. Anat. Rec. 1992, 232, 194-201.
10. Brgan C. E., Luger A. M., Martinez J., Muruve N., Nelsaon P. W., Pierce G. E., Ross G., Shield C. F., Warady B. A., Aeder M. I., Helling T. S.: Cold ischemia time; an independent predictor after rejection of a primary cadaveric renal allograft. Transplantation 2001, 71, 875-879.
11. Paul L. C.: Chronic renal transplant loss. Kidney Int. 1995, 47, 1491-1499.
12. Ylmaz S., Paavonen T., Hayry P.: Chronic rejection of rat renal allografts. The impact of prolonged ischemia on transplant histology. Transplantation 1992, 53, 823-827.
13. Ojo A. O., Wolfe R. A., Held P. J., Port F. K., Schmouder R. L.: Delayed graft function risk factor and implications for renal allograft survival. Transplantation 1997, 63, 968-974.
14. Boratyńska M., Szepietowski T., Szewczyk Z.: Acute rejection and delayed graft function - risk factors of graft loss. Ann. Transplant. 1996, 1, 19-22.
15. Yroppmann C., Gillingham K., Bendetti E., Almond P. S., Gruessner R. W. G., Najavian J. S., Matas A. J.: Delayed graft function, acute rejection and outcome after cadaveric renal transplantation. Transplantation 1995, 59, 962-968.
16. Almond P. S., Matas A., Gillingham K., Dunn D. L., Payne W. D., Gores P., Gruessner R., Najarian J. S.: Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993, 55, 752-757.
17. Gulanikar A. C., MacDonald A. S., Sungurtekin U., Belytsky P.: The incidence and impact of early rejection on graft outcome in recipients of first cadaveric kidney transplants. Transplantation 1992, 53, 323-328.
18. Van Saase J., van der Woude F. J., Throgood J., Hollander A. A., van Es L. A., Weening J. J., van Bockel J. H., Bruijn J. A.: The relation between acute vascular and interstitial renal allograft rejection and subsequent chronic rejection. Transplantation 1995, 59, 1280-1285.
19. Grenda R.: Ocena czynników wpływaja̧cych na rozwój przewlekłej nefropatii alloprzeszczepu nerki u dzieci. Centrum Zdrowia Dziecka, Warszawa 1998, 46-99.
20. Opelz G.: Effect of the maintenance immunosuppressive drug regimen on kidney transplant outcome. Transplantation 1994, 58, 443-445.
21. Dawidson I., Rooth P., Fry W. R., Sandor Z., Willms C., Coorpender L., Always C., Reisch J.: Prevention of acute cyclosporine induced renal blood flow inhibition and improved immunosuppression with verapamil in renal transplantation. Transplantation 1989, 48, 575-580.
22. Gunning T. C., Brown M. R., Swygert T. H., Goldstein R., Husberg B. S., Klintmalm G. B., DiBona G., Paulsen A. W., Ramsay M. A. E., Gonwa T. A.: Perioperative renal function in patients undergoing orthotopic liver transpolantation; a randomized trial of the effects of verapamil. Transplantation 1991, 51, 422-427.
23. Mattos A. M., Olyaei A. J., Bennett W. M.: Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for future. Am. J. Kid. Dis. 2000, 35, 333-346.
24. McNally P. G., Fechally J.: Pathophysiology of cylcosporine A nephrotoxicity experimental and clinical observations. Nephrol. Dial. Transplant. 1993, 7, 791-804.
25. Kahan B. D.: High variability of drug exposure a biopharmaceutic risk factor for chronic rejection. Transplant. Proc. 1998, 30, 1639-1641.
26. Mahalati K., Kahan B. D.: Pharmacological surrogates of allograft outcome. Ann. Transplant. 2000, 5, 14-23.
27. Opelz G., Wujciak T., Ritz E.: Association of chronic kidney graft failure with recipients blood pressure. Kidney Int. 1998, 53, 217-222.
28. Flechner S. M., Modlin C. S., Serrano D. P., Goldfarb D., Papajcik D., Mastroianni B., Goormastic M., Novick A.: Determinations of chronic renal allograft rejection in cyclosporine-terated recipients. Transplantation 1996, 62, 1235-1241.
29. Vathsala A., Verani R., Schoenberg L, Levis R. M., van Buren C. T., Kerman R. H., Kahan B. D.: Proteinuria in cyclosporine treated renal transplant recipients. Transplantation 1990, 49, 35-41.
30. Massy Z. A., Guijaro C., Wiederkehr M. R., Ma J. Z., Kasiske B. L.: Chronic renal allograft rejection. Immunologic and nonimmunologic risk factors. Kidney Int. 1996, 49, 518-524.
31. Hohage H., Kleyer U., Bruckner D., August C., Zidek W., Spieker C.: Inlfluence of proteinuria on long-term transplant survival in kidney transplant recipients. Nephron 1997, 75, 160-165.
32. Dimeny E., Wahlberg J., Lithell H., Fellstrom B.: Hyperlipidemia in renal transplantation; risk factor for long-term graft outcome. Eur. J. Clin. Invest. 1995, 25, 574-583.